Cargando…
Evaluating Health Span in Preclinical Models of Aging and Disease: Guidelines, Challenges, and Opportunities for Geroscience
Life extension is no longer considered sufficient evidence of delayed aging in research animals. It must also be demonstrated that a broad swathe of health indicators have been extended. During a retreat of the Geroscience Network, a consortium of basic and clinical aging researchers, potential meas...
Autores principales: | Huffman, Derek M., Justice, Jamie N., Stout, Michael B., Kirkland, James L., Barzilai, Nir, Austad, Steven N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055649/ https://www.ncbi.nlm.nih.gov/pubmed/27535967 http://dx.doi.org/10.1093/gerona/glw106 |
Ejemplares similares
-
Barriers to the Preclinical Development of Therapeutics that Target Aging Mechanisms
por: Burd, Christin E., et al.
Publicado: (2016) -
Frameworks for Proof-of-Concept Clinical Trials of Interventions That Target Fundamental Aging Processes
por: Justice, Jamie, et al.
Publicado: (2016) -
Strategies and Challenges in Clinical Trials Targeting Human Aging
por: Newman, John C., et al.
Publicado: (2016) -
Recent Progress in Metabolic Signaling Pathways Regulating Aging and Life Span
por: Newgard, Christopher B., et al.
Publicado: (2014) -
BIOMARKER STRATEGIES FOR GEROSCIENCE-GUIDED CLINICAL TRIALS
por: Justice, Jamie N, et al.
Publicado: (2019)